The percentage of CD19+ B cells among CD45+ lymphocytes in the peripheral blood of colorectal cancer patients did not differ significantly from healthy controls (8.4% vs. 5.1%, p=0.14, Fig. 1A). Here, PTPRC is linked to colorectal cancer.